Bioidentical hormones

References

• Bhavnani BR, Stanczyk FZ. Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. J Clin Endocrinol Metab 2012;97:756–9
   PubMed Web of Science ®Google Scholar
• Becchi M, Aguilera R, Farizon Y, et al. Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport. Rapid Commun Mass Spectrom 1994;8:304–8
   PubMed Web of Science ®Google Scholar
• Shoppee CW. Chemistry of the Steroids. London: Butterworths Scientific Publications; 1964, p. 105–27
   Google Scholar
• Akhrem AA, Titov YA. Total Steroid Synthesis. New York: Plenum Press; 1970, p. 247
   Google Scholar
• Simersky R, Novak O, Morris DA, et al. Identification and quantification of several mammalian steroid hormones in plants by UPLC-MS/MS. J Plant Growth Regul 2009;28:125–36
   Web of Science ®Google Scholar
• Zava DT, Groves MN, Stanczyk FZ. Percutaneous absorption of progesterone. Maturitas 2014;77:91–2
   PubMed Web of Science ®Google Scholar
• Bello SM, Mezrow G, Shoupe D, et al. Administration of progesterone by use of a percutaneous gel in postmenopausal women. Presented at the 45th Annual Meeting of the Pacific Coast Fertility Society, Indian Wells, CA, April 10–13, 1997
   Google Scholar
• Du JY, Sanchez P, Kim L, et al. Percutaneous progesterone delivery via cream or gel application in postmenopausal women: a randomized cross-over study of progesterone levels in serum, whole blood, saliva, and capillary blood. Menopause 2013;20:1169–75
   PubMed Web of Science ®Google Scholar
• Chang KJ, Lee TT, Linares-Cruz G, et al. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertil Steril 1995;63:785–91
   PubMed Web of Science ®Google Scholar
• Leonetti HB, Wilson KJ, Anasti JN. Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. Fertil Steril 2003;79:221–2
   PubMed Web of Science ®Google Scholar
• Landes J, Leonetti HB. Topical progesterone cream. An alternative progestin in hormonal replacement therapy. Obstet Gynecol 2003;101(Suppl 1):56
   Google Scholar
• Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric 2000;3:155–60
   PubMedGoogle Scholar
• Gröschl M. Saliva: a reliable sample matrix in bioanalytics. Bioanalysis 2017;9:655–68
   PubMed Web of Science ®Google Scholar
• Westphall U. Steroid–Protein Interactions. Berlin: Springer-Verlag, 1974
   Google Scholar
• Mendel CM. The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 1989;10:232–74
   PubMed Web of Science ®Google Scholar
• Manni A, Pardridge WM, Cefalu W, et al. Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab 1985;61:705–10
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 1986;15:259–78
   PubMedGoogle Scholar
• Shimojo M, Ricketts ML, Petrelli MD, et al. Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: evidence for nuclear localization. Endocrinology 1997;138:1305–11
   PubMed Web of Science ®Google Scholar
• Wood P. Salivary steroid assays - research or routine? Ann Clin Biochem 2009;46:183–96
   PubMed Web of Science ®Google Scholar
• Blom T, Ojanotko-Harri A, Laine M, et al. Metabolism of progesterone and testosterone in human parotid and submandibular salivary glands in vitro. J Steroid Biochem Mol Biol 1993;44:69–76
   PubMed Web of Science ®Google Scholar
• Spaan M, Porola P, Laine M, et al. Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjögren's syndrome. J Cell Mol Med 2009;13:1261–70
   PubMed Web of Science ®Google Scholar
• Flyckt RL, Liu J, Frasure H, et al. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo. Menopause 2009;16:680–8
   PubMed Web of Science ®Google Scholar
• Liu J, Qiu X, Wang D, et al. Quantification of 10 steroid hormones in human saliva from Chinese adult volunteers. J Int Med Res 2018;46:1414–27
   PubMed Web of Science ®Google Scholar
• The Endocrine Society. Position Statement on Bioidentical Hormones. Issued October 2006. Available at: https://www.endocrine.org/advocacy/position-statements/compounded-bioidentical-hormone-therapy
   Google Scholar
• Stanczyk FZ, Niu C, Azen C, Mirkin S, Amadio JM. Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies. Menopause 2019;26:966–71
   PubMed Web of Science ®Google Scholar
• Savla R, Browne J, Plassat V, Wasan KM, Wasan EK. Review and analysis of FDA approved drugs using lipid-based formulations. Drug Dev Ind Pharm 2017;43:1743–58
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; American Society for Reproductive Medicine Practice Committee. Compounded bioidentical menopausal hormone therapy. Fertil Steril 2012;98:308–12
   PubMed Web of Science ®Google Scholar
• Slater CC, Souter I, Zhang C, Guan C, Stanczyk FZ, Mishell DR. Pharmacokinetics of testosterone after percutaneous gel or buccal administration. Fertil Steril 2001;76:32–7
   PubMed Web of Science ®Google Scholar
• Eden JA, Hacker NF, Fortune M. Three cases of endometrial cancer associated with "bioidentical" hormone replacement therapy. Med J Aust 2007;187:244–5
   PubMed Web of Science ®Google Scholar
• Pinkerton JV, Pickar JH. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy. Menopause 2016;23:215–23
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Prescription drug labeling resources. Available at: https://www.fda.gov/drugs/laws-acts-and-rules/prescription-drug-labeling-resources
   Google Scholar
• Teshome BF, Reveles KR, Lee GC, et al. How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak. J Am Pharm Assoc (2003) 2014;54:441–5
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. 2018 Compounding Policy Priorities Plan. Available at: https://www.fda.gov/drugs/human-drug-compounding/2018-compounding-policy-priorities-plan
   Google Scholar
• National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Replacement Therapy; Jackson LM, Parker RM, Mattison DR, editors. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. Washington (DC): National Academies Press (US); 2020 Jul 1
   Google Scholar
• Boothby LA, Doering PL, Kipersztok S. Bioidentical hormone therapy: a review. Menopause 2004;11:356–67
   PubMed Web of Science ®Google Scholar
• Pinkerton JV. The truth about bioidentical hormone therapy. The Female Patient 2012;37:16–20
   Google Scholar